Breakthrough invasive mold infections (IMIs) that occur during posaconazole or voriconazole prophylaxis are rare complications for which epidemiological data are lacking. This retrospective analysis comparing 24 microbiologically documented breakthrough with 66 nonbreakthrough IMIs shows a shift towards non-Aspergillus molds with a significantly increased proportion of rare multidrug-resistant molds.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/cid/cix130 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!